Privately held Indian company, Biological E is investing $234 million in their three facilities in the Genome Valley of Hyderabad, India. The new infusion of funds will enhance the production capacity by five billion doses, increasing the cumulative capacity to about 14 billion doses per year. The company claims that...
India’s Health Ministry Clears Two New Vaccines, Anti-Viral Drug
The Central Drugs Standard Control Organization (CDSCO), drug regulator for India's Health Ministry, approved two more Covid vaccines, Corbevax and Covovax, as also the anti-viral drug Molnupiravir to treat adult patients with COVID-19 as also those who have a high risk of progression of the disease. Corbevax: This vaccine is...
Washington Galvanizes as India Battles Covid-19 Tsunami
On April 6, 2020 , as the United States was pummeled by the Covid-19 pandemic, Time Magazine lamented how India had blocked exports of a malaria drug that held potential to treat novel coronavirus patients. The President of the United States tweeted asking India for help and within just six...